Verastem, Inc. (VSTM)
6.58
+0.24
(+3.79%)
USD |
NASDAQ |
Apr 17, 16:00
6.575
0.00 (0.00%)
After-Hours: 20:00
Verastem Free Cash Flow : -147.13M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Johnson & Johnson | 19.70B |
| Merck & Co., Inc. | 12.36B |
| Altimmune, Inc. | -67.55M |
| Ocugen, Inc. | -57.15M |
| Xilio Therapeutics, Inc. | -5.51M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -29.95M |
| Cash from Investing (Quarterly) | -1.345M |
| Cash from Financing (Quarterly) | 98.58M |
| Free Cash Flow Per Share (Quarterly) | -0.3753 |
| Free Cash Flow to Equity (Quarterly) | -28.99M |
| Free Cash Flow to Firm (Quarterly) | -30.88M |
| Free Cash Flow Yield | -31.41% |